SEQENS Overview
SEQENS is a global leader in pharmaceutical solutions and specialty ingredients. They provide a range of products, including generic and custom APIs, intermediates, and excipients for pharmaceuticals, along with ingredients for personal care and specialty chemicals. With 16 production sites and 9 R&D centers across 9 countries, SEQENS serves over 1,500 customers in more than 80 countries. In 2021, Private equity group SK Capital Partners has completed the acquisition of a majority stake in French firm Seqens, at the same time merging portfolio company Wavelength Pharmaceuticals into Seqens.
Latest News
Team Members
1
Employees: 11-50
Web & Social Links
| Website | www.seqens.com/ |
Locations
Be'er Sheva, Israel
France
Photos & Videos
No files yet
SEQENS Business
Sector
—Target Customer
—Core Technology
—SEQENS Financials
SEQENS Lifecycle
SEQENS News
1 articleSEQENS Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 44 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
SEQENS Internal
Recent Updates
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 59/100 |
| Missing | product stage, sector, tags, business model, video or image, funding rounds, markets, not claimed |
| BI Verification | Maor Perlov |
| Creator | Maor Perlov |
| Creator email | maor.perlov@sncentral.org |
| Last update | 2024-10-06T00:00:00.000Z |
| Created | 2024-10-06T00:00:00.000Z |